Eye Journal
Response to: ‘Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’ – (Eye 29, 1630 (December 2015))
Response to: ‘Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’ Eye 29, 1630 (December 2015). doi:10.1038/eye.2015.191 Authors: N Homer, D S Grewal, R G Mirza, A T Lyon & M K Gill
Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions’ – (Eye 29, 1631 (December 2015))
Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions’ Eye 29, 1631 (December 2015). doi:10.1038/eye.2015.210 Author: D S J Ting
Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary’ – (Eye 29, 1631 (December 2015))
Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary’ Eye 29, 1631 (December 2015). doi:10.1038/eye.2015.219 Authors: D Călugăru & M Călugăru
The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary – (Eye 29, 1633 (December 2015))
The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary Eye 29, 1633 (December 2015). doi:10.1038/eye.2015.164 Authors: S Sivaprasad, W M Amoaku, P Hykin & RVO Guideline Group
Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data – (Eye 29, 1639 (December 2015))
Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data Eye 29, 1639 (December 2015). doi:10.1038/eye.2015.186 Authors: T Boodhna, L J Saunders & D P Crabb